Shares of Viking Therapeutics (NASDAQ: VKTX) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall Street analysts. Seedhouse doesn't beat around the bush: "Our thesis is ...

Viking Therapeutics has a 1 year low of $18.92 and a 1 year high of $81.86. The firm has a fifty day moving average price of $26.35 and a 200 day moving average price of $40.06.

Analysts at Cantor Fitzgerald started coverage on shares of Viking Therapeutics (NASDAQ:VKTX – Get Free Report) in a research report issued on Monday, MarketBeat Ratings reports. The brokerage s ...

All that being said, until the actual clinical trial data comes out, it's impossible to say for sure that the drug will be a success, or that Viking Therapeutics stock will go up as far and as ...

Altimmune and Viking Therapeutics have promising obesity drugs and could be great acquisition targets for Pfizer. Pfizer should be able to easily fund an acquisition of either small drugmaker.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn’t one of them. The 10 stocks that ...

On Tuesday, Cantor Fitzgerald began coverage of Viking Therapeutics (NASDAQ:VKTX) shares, assigning an Overweight rating and setting a price target at $104.00. According to InvestingPro data ...

On Tuesday, Cantor Fitzgerald began coverage of Viking Therapeutics (NASDAQ:VKTX) shares, assigning an Overweight rating and setting a price target at $104.00. According to InvestingPro data, analyst ...